DLH Awarded Contract for CDC NCHHSTP DHP Data Management Services
August 18 2021 - 8:27AM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a
leading provider of innovative healthcare research, services, and
solutions to federal agencies, today announced that it has been
awarded a contract by the Centers for Disease Control and
Prevention’s (“CDC”) Division of HIV Prevention (“DHP”) Data
Management Services through data management and analysis, health
informatics, and research support. The contract includes a base
period of one year, with four one-year options, for a total value
of $35 million.
“We are thrilled to partner with DHP in support
of their vision of a ‘future free of HIV,’” said Jeanine Christian,
President of DLH’s Public Health & Scientific Research
operating unit. “This contract extends DLH’s legacy in HIV research
across the globe. We are proud to bring our research and data
sciences capability to bear on the important work the CDC is doing
to assess opportunities to reduce the number of new HIV infections
occurring annually, increase the proportion of HIV-infected persons
who know they are infected, and increase the number of HIV-infected
persons who are linked to appropriate prevention, care, and
services.”
This contract augments DLH’s work in the Public
Health & Life Sciences market. The project involves
collaboration with epidemiologists, medical officers,
statisticians, computer scientists, data managers and analysts, and
public health advisors throughout the US. DLH will provide public
health data management services for qualitative and quantitative
scientific and non-scientific data, including research,
surveillance, program monitoring, evaluation, statistical analysis,
and reporting support.
“DLH is pleased to build upon its long-standing
relationships with CDC and DHP through this important work in
disease prevention,” added Zach Parker, President and CEO of DLH.
“This leverages several of the capabilities that we have developed
over recent years, and broadens our footprint in our nation’s fight
against the spread of infectious diseases.”
About DLH
DLH delivers improved health and readiness
solutions for federal programs through research, development, and
innovative care processes. The Company’s experts in public health,
performance evaluation, and health operations solve the complex
problems faced by civilian and military customers alike, leveraging
digital transformation, artificial intelligence, advanced
analytics, cloud-based applications, telehealth systems, and more.
With over 2,200 employees dedicated to the idea that “Your Mission
is Our Passion,” DLH brings a unique combination of government
sector experience, proven methodology, and unwavering commitment to
public health to improve the lives of millions. For more
information, visit www.DLHcorp.com.
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995:
This press release may contain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements relate to future events or
DLH`s future financial performance. Any statements that refer to
expectations, projections or other characterizations of future
events or circumstances or that are not statements of historical
fact (including without limitation statements to the effect that
the Company or its management “believes”, “expects”, “anticipates”,
“plans”, “intends” and similar expressions) should be considered
forward looking statements that involve risks and uncertainties
which could cause actual events or DLH’s actual results to differ
materially from those indicated by the forward-looking statements.
Forward-looking statements in this release include, among others,
statements regarding estimates of future revenues. These statements
reflect our belief and assumptions as to future events that may not
prove to be accurate. Our actual results may differ materially from
such forward-looking statements made in this release due to a
variety of factors, including: the outbreak of the novel
coronavirus (“COVID-19”), including the measures to reduce its
spread, and its impact on the economy and demand for our services,
are uncertain, cannot be predicted, and may precipitate or
exacerbate other risks and uncertainties; the risk that we will not
realize the anticipated benefits of our recent or any future
acquisition; the challenges of managing larger and more widespread
operations resulting from the acquisition; contract awards in
connection with re-competes for present business and/or competition
for new business; compliance with new bank financial and other
covenants; changes in client budgetary priorities; government
contract procurement (such as bid protest, small business set
asides, loss of work due to organizational conflicts of interest,
etc.) and termination risks; the ability to successfully integrate
the operations of our recent acquisition and any future
acquisitions; and other risks described in our SEC filings. For a
discussion of such risks and uncertainties which could cause actual
results to differ from those contained in the forward-looking
statements, see “Risk Factors” in the Company’s periodic reports
filed with the SEC, including our Annual Report on Form 10-K for
the fiscal year ended September 30, 2020, as well as subsequent
reports filed thereafter. The forward-looking statements contained
herein are not historical facts, but rather are based on current
expectations, estimates, assumptions and projections about our
industry and business. Such forward-looking statements are made as
of the date hereof and may become outdated over time. The Company
does not assume any responsibility for updating forward-looking
statements, except as may be required by law.
CONTACTS:
INVESTOR RELATIONSContact: Chris WittyPhone:
646-438-9385Email: cwitty@darrowir.com
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Apr 2023 to Apr 2024